Blujepa, the first new oral UTI antibiotic in 30 years, offers hope against antibiotic-resistant infections, improving ...

US health regulators have approved a new antibiotic to treat urinary tract infections, a problem affecting more than 100 ...

If you deal with recurrent UTIs, a new FDA-approved antibiotic called Blujepa could offer another treatment option—especially ...

The US Food and Drug Administration has approved a new type of antibiotic to treat urinary tract infections. The pill, ...

The FDA has approved the drug for use in women and girls over the age of 12 who suffer from uncomplicated urinary tract ...

The drug Blujepa, from drugmaker GSK, provides a new treatment option as bacteria increasingly become resistant to the ...

The Food and Drug Administration has approved a new antibiotic that can treat uncomplicated urinary tract infections, or ...

Urinary Tract Infections (UTIs) are a significant burden on global health, affecting millions of people each year and ...

The first-of-its-kind in-depth bacterial evolutionary map could pave the way for the development of precision treatments for ...

The second infection was also tied to a 50% or greater increase in several specific long-COVID conditions, including ...

This antibiotic is the first new FDA-approved medication for urinary tract infections in decades, and meets the need for new ...

The product -- called Blujepa -- was approved for the treatment of uncomplicated urinary tract infections in adult women and ...